Sanofi walks away from MyoKardia heart drug partnership, long before key data readout
Last June, MyoKardia launched its keenly anticipated pivotal trial for its genetically targeted lead heart drug. Data are expected next year, but partner …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
